TipRanks
Advertisement
Advertisement

ALNY Stock Latest News

Alnylam reports ALN-HTT02 clinical trial results
The FlyAlnylam reports ALN-HTT02 clinical trial results
1h ago
ALNY
Alnylam assumed with a Buy at UBS
PremiumThe Fly
Alnylam assumed with a Buy at UBS
8d ago
ALNY
Alnylam price target lowered to $253 from $256 at Wells Fargo
PremiumThe Fly
Alnylam price target lowered to $253 from $256 at Wells Fargo
9d ago
ALNY
Alnylam price target lowered to $320 from $340 at Citi
PremiumThe Fly
Alnylam price target lowered to $320 from $340 at Citi
9d ago
ALNY
Alnylam price target lowered to $336 from $346 at BofA
PremiumThe Fly
Alnylam price target lowered to $336 from $346 at BofA
14d ago
ALNY
Alnylam price target lowered to $345 from $350 at RBC Capital
PremiumThe FlyAlnylam price target lowered to $345 from $350 at RBC Capital
15d ago
ALNY
Alnylam price target lowered to $369 from $375 at JPMorgan
Premium
The Fly
Alnylam price target lowered to $369 from $375 at JPMorgan
23d ago
ALNY
Alnylam announces launch of AMVUTTRA ‘Play by Play’ initiative
Premium
The Fly
Alnylam announces launch of AMVUTTRA ‘Play by Play’ initiative
24d ago
ALNY
Overvalued Healthcare Stocks? Analysts See Upside in These 3 High P/E Names
PremiumMarket News
Overvalued Healthcare Stocks? Analysts See Upside in These 3 High P/E Names
1M ago
ALNY
BTSG
Analyst Maintains Buy Rating on Alnylam, Reiterates $357 Price Target on Long-Term Zilebesiran Opportunity
PremiumRatings
Analyst Maintains Buy Rating on Alnylam, Reiterates $357 Price Target on Long-Term Zilebesiran Opportunity
1M ago
ALNY
Hold Rating Reaffirmed as TTR Outlook Moderates; $300 Price Target Maintained
PremiumRatings
Hold Rating Reaffirmed as TTR Outlook Moderates; $300 Price Target Maintained
1M ago
ALNY
Alnylam price target raised to $260 from $230 at Jefferies
PremiumThe Fly
Alnylam price target raised to $260 from $230 at Jefferies
1M ago
ALNY
Alnylam’s Emerging TTR Leadership Reinforces Buy Rating with Unchanged $455 Price Target
PremiumRatingsAlnylam’s Emerging TTR Leadership Reinforces Buy Rating with Unchanged $455 Price Target
2M ago
ALNY
Whitney Ijem Reiterates Buy on Alnylam, Keeps Price Target Unchanged at $429 Following CARDIO‑TTRansform Data
Premium
Ratings
Whitney Ijem Reiterates Buy on Alnylam, Keeps Price Target Unchanged at $429 Following CARDIO‑TTRansform Data
2M ago
ALNY
Alnylam Upgraded to Buy on Strong ATTR Cardiomyopathy Positioning and Amvuttra Mega-Blockbuster Potential
Premium
Ratings
Alnylam Upgraded to Buy on Strong ATTR Cardiomyopathy Positioning and Amvuttra Mega-Blockbuster Potential
2M ago
ALNY
Alnylam Maintained at Buy as Analyst Reaffirms $346 Price Target on TTR Franchise Strength and Amvuttra Growth Visibility
PremiumRatings
Alnylam Maintained at Buy as Analyst Reaffirms $346 Price Target on TTR Franchise Strength and Amvuttra Growth Visibility
2M ago
ALNY
Alnylam announces new data at ESC Congress on AMVUTTRA
PremiumThe Fly
Alnylam announces new data at ESC Congress on AMVUTTRA
2M ago
ALNY
Ionis, AstraZeneca ATTR-CM trial did not meet primary endpoint
PremiumThe Fly
Ionis, AstraZeneca ATTR-CM trial did not meet primary endpoint
2M ago
AZN
ALNY
Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data
PremiumThe Fly
Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data
2M ago
AZN
ALNY
Trump Trade: U.S. considering new semiconductor tariffs
PremiumThe FlyTrump Trade: U.S. considering new semiconductor tariffs
2M ago
MU
AMD
White House to announce drug pricing deals with biotechs, Bloomberg reports
Premium
The Fly
White House to announce drug pricing deals with biotechs, Bloomberg reports
2M ago
ALKS
ALNY
Alnylam to present new clinical data on ATTR, hypertension at ESC Congress
Premium
The Fly
Alnylam to present new clinical data on ATTR, hypertension at ESC Congress
2M ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >